TLR4-Mediated Sensing of Campylobacter jejuni by Dendritic Cells Is Determined by Sialylation
暂无分享,去创建一个
H. Endtz | T. Luider | A. van Belkum | M. Kuijf | P. Burgers | Y. van Kooyk | R. Huizinga | W. van Rijs | J. Samsom | B. Jacobs | E. Nieuwenhuis | P. V. van Doorn | A. Heikema | M. Bax
[1] K. Hirata,et al. BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide , 2010, Journal of Neuroimmunology.
[2] H. Endtz,et al. The Sialylated Lipooligosaccharide Outer Core in Campylobacter jejuni Is an Important Determinant for Epithelial Cell Invasion , 2008, Infection and Immunity.
[3] S. Ram,et al. Human Factor H Interacts Selectively with Neisseria gonorrhoeae and Results in Species-Specific Complement Evasion1 , 2008, The Journal of Immunology.
[4] N. Yuki,et al. Axonal Guillain‐Barré syndrome: carbohydrate mimicry and pathophysiology , 2007, Journal of the peripheral nervous system : JPNS.
[5] C. Visser,et al. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] E. Steyerberg,et al. A clinical prognostic scoring system for Guillain-Barré syndrome , 2007, The Lancet Neurology.
[7] Jianjun Li,et al. Structural Characterization of Campylobacter jejuni Lipooligosaccharide Outer Cores Associated with Guillain-Barré and Miller Fisher Syndromes , 2007, Infection and Immunity.
[8] H. Willison,et al. Sialic Acid-Binding Immunoglobulin-Like Lectin 7 Mediates Selective Recognition of Sialylated Glycans Expressed on Campylobacter jejuni Lipooligosaccharides , 2006, Infection and Immunity.
[9] Soo Young Park,et al. Gangliosides trigger inflammatory responses via TLR4 in brain glia. , 2006, The American journal of pathology.
[10] D. Kopecko,et al. Campylobacter jejuni Induces Maturation and Cytokine Production in Human Dendritic Cells , 2006, Infection and Immunity.
[11] A. Lanzavecchia,et al. Toll‐like receptor stimulation as a third signal required for activation of human naive B cells , 2006, European journal of immunology.
[12] E. S. Baekkevold,et al. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. , 2005, Blood.
[13] H. Willison. The immunobiology of Guillain‐Barré syndromes , 2005, Journal of the peripheral nervous system : JPNS.
[14] Jianjun Li,et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. , 2004, The Journal of clinical investigation.
[15] K. Hirata,et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Meulstee,et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial , 2004, The Lancet.
[17] P. Crocker,et al. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake , 2003, Molecular Microbiology.
[18] A. Mantovani,et al. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. , 2003, Blood.
[19] J. Brisson,et al. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Clark,et al. Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. , 2003, Blood.
[21] B. Beutler,et al. Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.
[22] Douglas T. Golenbock,et al. Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction* 210 , 2002, The Journal of Biological Chemistry.
[23] Kazuro Furukawa,et al. Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides in Campylobacter jejuni Strains Associated with Guillain-Barré Syndrome , 2002, Infection and Immunity.
[24] B. Nardelli,et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL , 2002, Nature Immunology.
[25] M. Frosch,et al. Lipooligosaccharide and Polysaccharide Capsule: Virulence Factors of Neisseria meningitidis That Determine Meningococcal Interaction with Human Dendritic Cells , 2002, Infection and Immunity.
[26] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[27] H. Endtz,et al. Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients , 2002, Infection and Immunity.
[28] H. Endtz,et al. A Campylobacter jejuni gene associated with immune-mediated neuropathy , 2001, Nature Medicine.
[29] P. Ricciardi-Castagnoli,et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.
[30] A. Moran,et al. Chemical structure of a polysaccharide from Campylobacter jejuni 176.83 (serotype O:41) containing only furanose sugars. , 1999, Carbohydrate research.
[31] M. Swash,et al. IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome , 1999, Neurology.
[32] P. Schmitz,et al. The spectrum of antecedent infections in Guillain-Barré syndrome , 1998, Neurology.
[33] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[34] H. Endtz,et al. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome , 1997, Journal of Neuroimmunology.
[35] Christophe Caux,et al. Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes , 1997, The Journal of experimental medicine.
[36] H. Endtz,et al. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. , 1997, The Journal of infectious diseases.
[37] M. Blaser,et al. Campylobacter jejuni and the expanding spectrum of related infections. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] G. Guazzi,et al. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy , 1993, Journal of Neuroimmunology.
[39] M. Swash,et al. I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome. , 1999, Neurology.
[40] D. Cornblath,et al. Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.